Ron Paul Pharmaceuticals is interested in acquiring Old Drugs Ltd. The projected cash flow statement for Old
Fantastic news! We've Found the answer you've been seeking!
Question:
Ron Paul Pharmaceuticals is interested in acquiring Old Drugs Ltd. The projected cash flow statement for Old Drugs after the merger is shown below, and these cash flows are estimated to grow at a constant rate of 6 percent per year:
Net revenues $305.6
Operating expenses $244.8
Depreciation $16.0
Earnings before interest and taxes (EBIT) $44.8
Interest $12.3
Earnings before taxes $32.5
Taxes $11.4
Net profit $21.1
Estimated retentions $19.2
The mean market multiple of recent pharmaceutical mergers is 10.265 times the EBITDA.
Estimate the equity value of Old Drugs Ltd. using the market multiple method.
Related Book For
Introduction to Management Science A Modeling and Cases Studies Approach with Spreadsheets
ISBN: 978-0078024061
5th edition
Authors: Frederick S. Hillier, Mark S. Hillier
Posted Date: